| All (n = 62) | No poAF (n = 41) | poAF (n = 21) | p-value |
---|---|---|---|---|
Female gender | 27 (44%) | 17 (41%) | 10 (47%) | 0.85 |
Age (mean) | 58.7 | 56.0 | 64.8 | 0.006 |
Past Medical History | ||||
Smoking (Any) | 21 (32%) | 12 (29%) | 8 (38%) | 0.68 |
Myocardial Infarction | 2 (3%) | 1 (2%) | 1 (5%) | 1.00 |
Hypertension | 34 (55%) | 18 (44%) | 17 (81%) | 0.01 |
Diabetes | 7 (11%) | 4 (11%) | 3 (15%) | 0.94 |
Atrial fibrillation | 12 (19%) | 7 (17%) | 5 (24%) | 0.76 |
Mitral Stenosis (severe) | 5 (8%) | 3 (8%) | 2 (11%) | 0.65 |
Mitral Insufficiency | ||||
None | 1 (2%) | 0 (0%) | 1 (5%) | Â |
Mild | 1 (2%) | 1 (2%) | 0 (0%) | Â |
Moderate | 5 (8%) | 4 (10%) | 1 (5%) | Â |
Severe | 55 (89%) | 36 (88%) | 19 (90%) | 0.48 |
Preoperative medications | ||||
ACE inhibitor /ARB | 27 (44%) | 16 (39%) | 12 (57%) | 0.28 |
β-blockers | 29 (47%) | 18 (44%) | 10 (48%) | 0.99 |
Calcium channel inhibitors | 8 (13%) | 7 (17%) | 1 (5%) | 0.38 |
HMG-CoA reductase inhibitor | 19 (31%) | 9 (21%) | 10 (50%) | 0.05 |
Perioperative information | ||||
Left ventricular ejection fraction | 0.60 | 0.61 | 0.59 | 0.39 |
Left atrium volume (ml/m2) | 71 | 70 | 73 | 0.75 |
Cross-clamp time (min) | 106 | 108 | 101 | 0.58 |
Cardiopulmonary bypass time (min) | 144 | 146 | 143 | 0.85 |